Jubilant Pharmova Ltd (JUBLPHARMA) Stock Price & News

JUBLPHARMA:NSE

Jubilant Pharmova Ltd

₹933.50

-0.58%

(-5.40) 1D

Oct 15, 3:30:00 PM GMT+5:30 · INR

All symbols

	Symbol	Price	Change	% Change

Last report

Aug 10, 2026

Fiscal period

Q1 2027

₹3.56 / ₹5.80

-38.62%miss

Revenue / Est. (INR)

22.29B / 22.62B

-1.44%miss

Fiscal Q1 2027 earnings call

Waiting for the earnings call

At a glance

Insights from the latest news and reports

Previous reportsAll values in INR

Loading Previous Earnings...

All values in INR	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	19.66B	21.22B	22.90B	22.29B
Cost of goods sold	5.96B	7.16B	9.53B	7.49B
Cost of revenue	5.96B	7.16B	9.53B	7.49B
Research and development expenses	-	-	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	6.36B	7.06B	8.34B	7.54B
Operating expense	11.33B	12.37B	11.14B	13.60B
Total operating expenses	17.30B	19.54B	20.68B	21.09B
Operating income	2.37B	1.69B	2.22B	1.21B
Other non operating income	98.00M	205.00M	-369.00M	199.00M
EBT including unusual items	1.90B	934.00M	1.76B	864.00M
EBT excluding unusual items	1.96B	1.33B	1.87B	864.00M
Income tax expense	704.00M	376.00M	567.00M	300.00M
Effective tax rate	36.99%	40.26%	32.22%	34.72%
Other operating expenses	3.92B	4.10B	1.63B	4.79B
Net income	1.20B	559.00M	1.19B	565.00M
Net profit margin	6.12%	2.63%	5.21%	2.53%
Earnings per share	7.85	5.01	8.10	3.56
Interest and investment income	-	-	252.00M	-
Interest expense	-502.00M	-561.00M	-461.00M	-542.00M
Net interest expenses	-502.00M	-561.00M	-209.00M	-542.00M
Depreciation and amortization charges	1.05B	1.21B	1.17B	1.27B
EBITDA	3.38B	2.30B	2.98B	1.96B
Gain or loss from assets sale	-	-	-	-

Finance